USPTO serial 87143093
ROVIVZEL
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- SCHWAB, MATTHEW DAVID
- Law office
- GENERIC WEB UPDATE
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ROVIVZEL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Camille M. Miller
CAMILLE M. MILLER COZEN O'CONNOR1650 MARKET STREETSUITE 2800PHILADELPHIA, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodysplastic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 13, 2017 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Mar 13, 2017 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Mar 8, 2017 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Mar 7, 2017 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Mar 7, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Mar 7, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 15, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Feb 2, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 18, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 6, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 6, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 15, 2016 | ALIE | ASSIGNED TO LIE | — |
| Dec 1, 2016 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 21, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 21, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 21, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 16, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 23, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 22, 2016 | NWAP | NEW APPLICATION ENTERED | — |